Vitamin D deficiency, myositis–myalgia, and reversible statin intolerance

References

• Holick MF, Chen TC. Vitamin D deficiency: a worldwide problem with health consequences. Am J Clin Nutr 2008;87:1080S-6S
   PubMed Web of Science ®Google Scholar
• Mark S, Gray-Donald K, Delvin EE, et al. Low vitamin D status in a representative sample of youth from Quebec, Canada. Clin Chem 2008;54:1283-9
   PubMed Web of Science ®Google Scholar
• Goswami R, Mishra SK, Kochupillai N. Prevalence & potential significance of vitamin D deficiency in Asian Indians. Indian J Med Res 2008;127:229-38
   PubMed Web of Science ®Google Scholar
• Alsafwah S, Laguardia SP, Nelson MD, et al. Hypovitaminosis D in African Americans residing in Memphis, Tennessee with and without heart failure. Am J Med Sci 2008;335:292-7
   PubMed Web of Science ®Google Scholar
• Kumar J, Muntner P, Kaskel FJ, et al. Prevalence and associations of 25-hydroxyvitamin D deficiency in US children: NHANES 2001–2004. Pediatrics 124(3):E362-370, 2009 ePUB
   Google Scholar
• Draeger A, Monastyrskaya K, Mohaupt M, et al. Statin therapy induces ultrastructural damage in skeletal muscle in patients without myalgia. J Pathol 2006;210:94-102
   PubMed Web of Science ®Google Scholar
• Adams JS, Hewison M. Update in vitamin D. J Clin Endocrinol Metab 2010;95:471-8
   PubMed Web of Science ®Google Scholar
• Jorde R, Sneve M, Hutchinson M, et al. Tracking of serum 25-hydroxyvitamin D levels during 14 years in a population-based study and during 12 months in an intervention study. Am J Epidemiol 2010;171:903-8
   PubMed Web of Science ®Google Scholar
• Erkal MZ, Wilde J, Bilgin Y, et al. High prevalence of vitamin D deficiency, secondary hyperparathyroidism and generalized bone pain in Turkish immigrants in Germany: identification of risk factors. Osteoporos Int 2006;17:1133-40
   PubMed Web of Science ®Google Scholar
• Zittermann A. Vitamin D in preventive medicine: are we ignoring the evidence? Br J Nutr 2003;89:552-72
   PubMed Web of Science ®Google Scholar
• Pfeifer M, Begerow B, Minne HW. Vitamin D and muscle function. Osteoporos Int 2002;13:187-94
   PubMed Web of Science ®Google Scholar
• Shinchuk LM, Holick MF. Vitamin D and rehabilitation: improving functional outcomes. Nutr Clin Pract 2007;22:297-304
   PubMed Web of Science ®Google Scholar
• Bischoff-Ferrari HA, Dietrich T, Orav EJ, et al. Higher 25-hydroxyvitamin D concentrations are associated with better lower-extremity function in both active and inactive persons aged > or =60 y. Am J Clin Nutr 2004;80:752-8
   PubMed Web of Science ®Google Scholar
• Lips P. Vitamin D physiology. Prog Biophys Mol Biol 2006;92:4-8
   PubMed Web of Science ®Google Scholar
• Targher G, Bertolini L, Padovani R, et al. Serum 25-hydroxyvitamin D3 concentrations and carotid artery intima-media thickness among type 2 diabetic patients. Clin Endocrinol (Oxf) 2006;65:593-7
   PubMed Web of Science ®Google Scholar
• Bunout D, Barrera G, Leiva L, et al. Effects of vitamin D supplementation and exercise training on physical performance in Chilean vitamin D deficient elderly subjects. Exp Gerontol 2006;41:746-52
   PubMed Web of Science ®Google Scholar
• Ghatak A, Faheem O, Thompson PD. The genetics of statin-induced myopathy. Atherosclerosis 2010;210(3):337-43
   Google Scholar
• Voora D, Shah SH, Spasojevic I, et al. The SLCO1B1*5 genetic variant is associated with statin-induced side effects. J Am Coll Cardiol 2009;54:1609-16
   PubMed Web of Science ®Google Scholar
• Glueck CJ, Aregawi D, Agloria M, et al. Rosuvastatin 5 and 10 mg/d: a pilot study of the effects in hypercholesterolemic adults unable to tolerate other statins and reach LDL cholesterol goals with nonstatin lipid-lowering therapies. Clin Ther 2006;28:933-42
   PubMed Web of Science ®Google Scholar
• Siddiqi SA, Thompson PD. How do you treat patients with myalgia who take statins? Curr Atheroscler Rep 2009;11:9-14
   PubMed Web of Science ®Google Scholar
• Lee P, Greenfield JR, Campbell LV. Vitamin D insufficiency – a novel mechanism of statin-induced myalgia? Clin Endocrinol (Oxf) 2009;71:154-5
   PubMed Web of Science ®Google Scholar
• Ahmed W, Khan N, Glueck CJ, et al. Low serum 25 (OH) vitamin D levels (<32 ng/mL) are associated with reversible myositis–myalgia in statin-treated patients. Transl Res 2009;153:11-16
   PubMed Web of Science ®Google Scholar
• Nichols GA, Koro CE. Does statin therapy initiation increase the risk for myopathy? An observational study of 32,225 diabetic and nondiabetic patients. Clin Ther 2007;29:1761-70
   PubMed Web of Science ®Google Scholar
• McClure DL, Valuck RJ, Glanz M, et al. Statin and statin-fibrate use was significantly associated with increased myositis risk in a managed care population. J Clin Epidemiol 2007;60:812-18
   PubMed Web of Science ®Google Scholar
• Bell DS. Resolution of statin-induced myalgias by correcting vitamin D deficiency. South Med J 2010;103:690-2
   PubMed Web of Science ®Google Scholar
• Perez-Castrillon JL, Vega G, Abad L, et al. Effects of atorvastatin on vitamin D levels in patients with acute ischemic heart disease. Am J Cardiol 2007;99:903-5
   PubMed Web of Science ®Google Scholar
• Yavuz B, Ertugrul DT, Cil H, et al. Increased levels of 25 hydroxyvitamin D and 1,25-dihydroxyvitamin D after rosuvastatin treatment: a novel pleiotropic effect of statins? Cardiovasc Drugs Ther 2009;23:295-9
   PubMed Web of Science ®Google Scholar
• Rejnmark L, Vestergaard P, Heickendorff L, et al. Simvastatin does not affect vitamin D status, but low vitamin D levels are associated with dyslipidemia: results from a randomised, controlled trial. Int J Endocrinol 2010;2010:957174
   PubMedGoogle Scholar
• Tsugawa N, Suhara Y, Kamao M, et al. Determination of 25-hydroxyvitamin D in human plasma using high-performance liquid chromatography – tandem mass spectrometry. Anal Chem 2005;77:3001-7
   PubMed Web of Science ®Google Scholar
• Kennel KA, Drake MT, Hurley DL. Vitamin D deficiency in adults: when to test and how to treat. Mayo Clin Proc 2010;85:752-7
   PubMed Web of Science ®Google Scholar
• Grundy SM, Cleeman JI, Merz CN, et al. Implications of recent clinical trials for the National Cholesterol Education Program Adult Treatment Panel III guidelines. Circulation 2004;110:227-39
   PubMed Web of Science ®Google Scholar
• Sniderman AD. Is there value in liver function test and creatine phosphokinase monitoring with statin use? Am J Cardiol 2004;94:30F-4F
   PubMed Web of Science ®Google Scholar
• Glueck CJ, Rawal B, Khan NA, et al. Should high creatine kinase discourage the initiation or continuance of statins for the treatment of hypercholesterolemia? Metabolism 2009;58:233-8
   PubMed Web of Science ®Google Scholar
• Thompson PD, Clarkson P, Karas RH. Statin-associated myopathy. JAMA 2003;289:1681-90
   PubMed Web of Science ®Google Scholar
• Ginde AA, Liu MC, Camargo CA Jr. Demographic differences and trends of vitamin D insufficiency in the US population, 1988–2004. Arch Intern Med 2009;169:626-32
   PubMed Web of Science ®Google Scholar
• Duell PBCW. Vitamin D deficiency is associated with myalgias in hyperlipidemic subjects taking statins (Abstract). Circulation 2008;118:Suppl S470
   Web of Science ®Google Scholar
• Link E, Parish S, Armitage J, et al. SLCO1B1 variants and statin-induced myopathy – a genomewide study. N Engl J Med 2008;359:789-99
   PubMed Web of Science ®Google Scholar
• Fuleihan GE, Deeb M. Hypovitaminosis D in a sunny country. N Engl J Med 1999;340:1840-1
   PubMed Web of Science ®Google Scholar
• Nesby-O'Dell S, Scanlon KS, Cogswell ME, et al. Hypovitaminosis D prevalence and determinants among African American and white women of reproductive age: third National Health and Nutrition Examination Survey, 1988–1994. Am J Clin Nutr 2002;76:187-92
   PubMed Web of Science ®Google Scholar
• Hannan MT, Litman HJ, Araujo AB, et al. Serum 25-hydroxyvitamin D and bone mineral density in a racially and ethnically diverse group of men. J Clin Endocrinol Metab 2008;93:40-6
   PubMed Web of Science ®Google Scholar